XBiotech Statistics

Total Valuation

XBiotech has a market cap or net worth of $181.83 million. The enterprise value is -$9.21 million.

Market Cap	181.83M
Enterprise Value	-9.21M

Important Dates

The next estimated earnings date is Friday, August 9, 2024, after market close.

Earnings Date	Aug 9, 2024
Ex-Dividend Date	n/a

Share Statistics

XBiotech has 30.46 million shares outstanding. The number of shares has increased by 0.02% in one year.

Shares Outstanding	30.46M
Shares Change (YoY)	+0.02%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	35.14%
Owned by Institutions (%)	13.51%
Float	19.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.87
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.03, with a Debt / Equity ratio of 0.05.

Current Ratio	12.03
Quick Ratio	n/a
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -14.00% and return on invested capital (ROIC) is -18.80%.

Return on Equity (ROE)	-14.00%
Return on Assets (ROA)	-13.40%
Return on Capital (ROIC)	-18.80%
Revenue Per Employee	n/a
Profits Per Employee	-$374,915
Employee Count	82
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, XBiotech has paid $305,000 in taxes.

Income Tax	305,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.50% in the last 52 weeks. The beta is 1.38, so XBiotech's price volatility has been higher than the market average.

Beta (5Y)	1.38
52-Week Price Change	+13.50%
50-Day Moving Average	6.81
200-Day Moving Average	5.84
Relative Strength Index (RSI)	46.35
Average Volume (20 Days)	230,364

Short Selling Information

The latest short interest is 563,072, so 1.85% of the outstanding shares have been sold short.

Short Interest	563,072
Short Previous Month	657,300
Short % of Shares Out	1.85%
Short % of Float	2.84%
Short Ratio (days to cover)	2.52

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-41.22M
Pretax Income	-30.44M
Net Income	-30.74M
EBITDA	-28.71M
EBIT	-30.44M
Earnings Per Share (EPS)	-$1.02

Full Income Statement

Balance Sheet

The company has $201.04 million in cash and $10.00 million in debt, giving a net cash position of $191.04 million or $6.27 per share.

Cash & Cash Equivalents	201.04M
Total Debt	10.00M
Net Cash	191.04M
Net Cash Per Share	$6.27
Equity (Book Value)	209.28M
Book Value Per Share	6.87
Working Capital	186.17M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$21.12 million and capital expenditures -$611,000, giving a free cash flow of -$21.73 million.

Operating Cash Flow	-21.12M
Capital Expenditures	-611,000
Free Cash Flow	-21.73M
FCF Per Share	-$0.71

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

XBiotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.02%
Shareholder Yield	-0.02%
Earnings Yield	-16.91%
FCF Yield	-11.95%

Dividend Details

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1